Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling

Search results

• Finished

  Targeting hypermutable 'superbugs' in chronic respiratory infections by optimised antibiotic combination dosage regimens

  Landersdorfer, C. (Primary Chief Investigator (PCI)), Boyce, J. (Chief Investigator (CI)), Bulitta, J. (Chief Investigator (CI)), Nation, R. (Chief Investigator (CI)) & Oliver, A. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/16 → 31/12/19

  Project: Research

• Targeting bacterial 'superbugs' by innovative combination dosing strategies and new antibiotics

  Bulitta, J. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/03/15 → 28/02/19

  Project: Research

• Combating bacterial 'superbugs' by innovative antibiotic combination strategies

  Landersdorfer, C. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/14 → 31/12/17

  Project: Research

• Combating bacterial 'superbugs' by innovative dosing strategies that combine available antibiotics to prevent resistance

  Landersdorfer, C. (Primary Chief Investigator (PCI)), Boyce, J. (Chief Investigator (CI)), Bulitta, J. B. B. (Chief Investigator (CI)), Kirkpatrick, C. (Chief Investigator (CI)), Nation, R. (Chief Investigator (CI)), Oliver, A. (Chief Investigator (CI)) & Velkov, T. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/13 → 31/12/16

  Project: Research